Stock Markets June 1, 2026 06:53 AM

ERock Begins IPO Roadshow Ahead of NYSE Listing as EROC

Power solutions provider files S-1 and markets 27.9 million Class A shares with $20-$23 price range

By Jordan Park

ERock Inc. has initiated the roadshow for an initial public offering of 27,906,977 Class A shares, proposing a price range of $20.00 to $23.00 per share. The offering includes a 30-day underwriter option for up to 4,186,046 additional shares. The company aims to list its Class A common stock on the New York Stock Exchange under the ticker EROC, and has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission that is not yet effective. The deal will be led by Morgan Stanley and J.P. Morgan, with a syndicate of bookrunners supporting distribution. Preliminary prospectus copies will be available through the lead underwriters, and no securities may be sold until the registration statement becomes effective.

ERock Begins IPO Roadshow Ahead of NYSE Listing as EROC

Key Points

  • ERock is marketing 27,906,977 Class A common shares with an expected price range of $20.00 to $23.00 per share - impacts capital markets activity in equity issuance.
  • Underwriters have a 30-day option to purchase up to 4,186,046 additional shares to cover over-allotments - relevant for potential share supply in the offering.
  • Morgan Stanley and J.P. Morgan are joint lead bookrunning managers, supported by a syndicate including Barclays, BofA Securities, Evercore ISI, Guggenheim Securities, Wolfe | Nomura Alliance and BNP Paribas - shows a broad institutional distribution effort.

ERock Inc. has launched the investor roadshow for its planned initial public offering, signaling its intent to list on the New York Stock Exchange under the ticker symbol "EROC." The company is marketing 27,906,977 shares of Class A common stock with an expected price range of $20.00 to $23.00 per share.

In connection with the offering, ERock has granted the underwriting syndicate a 30-day option to acquire up to an additional 4,186,046 shares to cover potential over-allotments. The firm characterizes itself as a provider of large-scale onsite power solutions.

Underwriting leadership for the deal is being shared by Morgan Stanley and J.P. Morgan, which are named as joint lead bookrunning managers. Barclays and BofA Securities are listed as joint bookrunning managers, while Evercore ISI, Guggenheim Securities, Wolfe | Nomura Alliance and BNP Paribas are acting as bookrunners.

The company has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission. That filing has not yet become effective; accordingly, ERock notes that no securities may be sold until the registration statement achieves effectiveness.

The transaction will be conducted through a prospectus. Preliminary copies of the prospectus are expected to be made available through the lead underwriters, per the company’s statement.


Context and mechanics of the offering

The centerpiece of the offering is the base allotment of 27,906,977 Class A common shares, with the underwriters able to exercise a 30-day option to increase the total by up to 4,186,046 additional shares. The range of $20.00 to $23.00 per share is presented as the expected pricing band for the offering; final pricing will be determined closer to the completion of the registration process.

Distribution responsibilities are divided among a multi-bank syndicate, with Morgan Stanley and J.P. Morgan taking primary leadership roles in bookrunning. Several other global and regional firms are participating as bookrunners to support placement of the shares.


Regulatory status and next steps

ERock’s registration statement remains pending with the SEC and has not yet become effective. The company has emphasized that sales cannot occur until the registration statement is effective and the prospectus process is complete. Preliminary prospectus materials will be available through the lead underwriters during the marketing period.

Risks

  • The registration statement on Form S-1 filed with the SEC has not yet become effective; no securities may be sold until effectiveness is achieved - regulatory timing risk affecting deal completion (markets and financial services sectors).
  • The offering’s price range is stated as an expected band and not final; actual pricing may differ when the offering is priced - pricing uncertainty for investors (capital markets).
  • Underwriters hold a 30-day option to purchase additional shares for over-allotments, which could increase the total number of shares sold if exercised - potential change in share supply during the offering (equities and corporate finance).

More from Stock Markets

U.S. Officials Held Early Talks on Taking Equity Stakes in AI Firms, NOTUS Says Jun 4, 2026 Japan Sees Real Wages Climb 1.9% in April; Household Spending Drops Less Than Anticipated Jun 4, 2026 Keystone Acquisition Completes $288.22 Million IPO and Private Warrant Placement Jun 4, 2026 U.S. Futures Slip as Tech Retreats; Markets Await Jobs Report Jun 4, 2026 U.S. Officials Hold Early Talks About Acquiring Equity Stakes in AI Firms Jun 4, 2026